Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection
T Xiang, B Liang, H Wang, X Quan, S He… - Cellular & molecular …, 2021 - nature.com
… in compensated cirrhotic patients still outweighs the vaccine-related risk. Next, we determined
the immunogenicity of CHB patients who completed the two doses of the vaccination …
the immunogenicity of CHB patients who completed the two doses of the vaccination …
Nonhuman primate models to evaluate vaccine safety and immunogenicity
RC Kennedy, MH Shearer, W Hildebrand - Vaccine, 1997 - Elsevier
… a number of human infectious diseases and tumors… vaccine safety and immunogenicity are
briefly discussed. Comparative immunology, reproductive physiology, endogenous infectious …
briefly discussed. Comparative immunology, reproductive physiology, endogenous infectious …
Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60
AR Falsey, EE Walsh - Vaccine, 1996 - Elsevier
… RSV infections in the placebo group and none in the vaccine group. Thus, PFP-2 was found
to be safe and immunogenic in healthy older adults. Copyright 0 1996 Elsevier Science Ltd. …
to be safe and immunogenic in healthy older adults. Copyright 0 1996 Elsevier Science Ltd. …
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries
PA Patriarca, PF Wright, TJ John - Reviews of infectious …, 1991 - academic.oup.com
… vaccine virus and enteric pathogens often interfere with responses to types 1 and 3 vaccine
viruses … , in view of the prolonged excretion of vaccine virus and the potential for interference …
viruses … , in view of the prolonged excretion of vaccine virus and the potential for interference …
Assessment of immunogenicity and neutralisation efficacy of viral-vectored vaccines against chikungunya virus
… tested the immunogenicity of our viral-vectored vaccines by … Our data shows that the T
cell immunogenicity elicited by … licensed vaccine is yet available to prevent CHIKV infection. …
cell immunogenicity elicited by … licensed vaccine is yet available to prevent CHIKV infection. …
Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old
DA Tristram, RC Welliver, CK Mohar… - Journal of Infectious …, 1993 - academic.oup.com
… in the cotton rat model ofRSV infection [4, 5]. The present study was undertaken to evaluate
the safety and immunogenicity of an RSV F protein vaccine in previously infected 18- to 36-…
the safety and immunogenicity of an RSV F protein vaccine in previously infected 18- to 36-…
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
SE Frey, M Houghton, S Coates, S Abrignani, D Chien… - Vaccine, 2010 - Elsevier
… for an effective vaccine to protect against infection and/or disease due to hepatitis C virus
(HCV… system is that the vaccine may not be strongly immunogenic for virus neutralization, there …
(HCV… system is that the vaccine may not be strongly immunogenic for virus neutralization, there …
Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012–2013
S Cobey, S Gouma, K Parkhouse… - Clinical Infectious …, 2018 - academic.oup.com
… Influenza vaccination aims to prevent infection by influenza virus and reduce associated …
the vaccine strain. Instead, low VE might have been caused by low vaccine immunogenicity in a …
the vaccine strain. Instead, low VE might have been caused by low vaccine immunogenicity in a …
Immunogenicity and efficacy of heterologous ChAdOx1–BNT162b2 vaccination
B Pozzetto, V Legros, S Djebali, V Barateau, N Guibert… - Nature, 2021 - nature.com
… mice have demonstrated the strong immunogenicity of the ChAd–… vaccination confers better
protection against infection—which is associated with more switched mBCs and higher virus …
protection against infection—which is associated with more switched mBCs and higher virus …
Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity …
… , inactivated influenza vaccine (TIV) in HIV-infected adults, particularly in Africa, are limited.
This study evaluated the safety, immunogenicity, and efficacy of TIV in HIV-infected adults. …
This study evaluated the safety, immunogenicity, and efficacy of TIV in HIV-infected adults. …